Discover

News & Info

Quote List Quote List

Ascentage Pharma(AAPG.US)

Event Tracking

Mar18

Ascentage Pharma to Release FY2025 Annual Earnings on March 25, 2026 After-Market EST, Forecast Revenue USD 79.48 M, EPS USD -1.1604

01:28

Jan15

Ascentage Pharma Reviews 2025 Milestones and Lays Out 2026 Global Strategy at J.P. Morgan Healthcare Conference

15:12

Jan7

Yashen Medicine's New Drug APG-3288 Receives FDA Clinical Approval

05:48

Dec9

Ascentage Pharma Presents Phase III POLARIS-1 Study Data at 2025 ASH Meeting

00:48

Dec6

Yabio Pharmaceuticals Presents Lisaftoclax Efficacy Data for Chronic Lymphocytic Leukemia

15:18

Aug21

Ascentage Pharma released FY2025 Q1 earnings on August 20 (EST), actual revenue USD 16.09 M, actual EPS USD -0.4763

03:00

Schedules & Filings

Schedules

Filings

Mar25

Earning Release(EST)

FY2025 Annual Earning Release

Aug20

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 16.29 M, Net Income -41.19 M, EPS -0.4824

Aug19

Earning Release(EST)

FY2025 Semi-Annual Earning Release

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More